What is AC Immune Ltd (ACIU) stock price today?

AC Immune Ltd (ACIU) currently trades at $2.97 per share. The stock has a market capitalization of $303.29M and a P/E ratio of —x.

Is ACIU stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, AC Immune Ltd has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -2.28.

What is AC Immune Ltd's revenue and earnings?

AC Immune Ltd has trailing twelve-month (TTM) revenue of $3.57M with profit margins of 0.00%. Earnings per share (EPS) is $-0.84.

Is AC Immune Ltd financially healthy?

AC Immune Ltd's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -2.28 places it in the distress.

ACIU

AC Immune Ltd

NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY

$2.97

-1.33% today

Updated 2026-05-06

Market cap

$303.29M

P/E ratio

—

P/S ratio

84.88x

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$2 – $4

Volume

0.3M

Market cap

$303.29M

P/E ratio

—

P/S ratio

84.88x

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$2 – $4

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-2.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$9.07

+205.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.07x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -2.28 — distress zone

- Thin margins at 0.00%

- Revenue declining -70.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$3.94M	$14.80M	$27.31M	$3.57M	$3.57M
Net income	$-70.75M	$-54.23M	$-50.92M	$-70.45M	$-14.80M
EPS	—	—	—	—	$-0.84
Free cash flow	$-74.81M	$-61.21M	$65.27M	$-67.01M	—
Profit margin	-1,798.04%	-366.41%	-186.44%	-1,971.65%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ACIU	$303.29M	16	2.7	2.5	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

AC Immune Ltd trades at $2.97. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -2.28, it sits in the distress. TTM revenue stands at $3.57M.

Frequently asked questions

What is AC Immune Ltd's stock price?

AC Immune Ltd (ACIU) trades at $2.97.

Is AC Immune Ltd overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of AC Immune Ltd (ACIU)?

The analyst target price is $9.07, representing +205.4% upside from the current price of $2.97.

What is AC Immune Ltd's revenue?

TTM revenue is $3.57M.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-2.28 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.acimmune.com

Quick metrics

P/S ratio84.88x

ROE-89.60%

Beta1.63

50D MA$2.94

200D MA$2.90

Shares out0.10B

Float0.04B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ACIU vs LLY →ACIU vs JNJ →ACIU vs ABBV →Stock screener →